Hydrophobic Interaction Chromatography Market Analysis

Hydrophobic Interaction Chromatography Segmentation

Sample (Monoclonal Antibodies, Vaccines)

The monoclonal antibodies segment is estimated to hold 38% share of the global hydrophobic interaction chromatography market by 2037. There has been a significant increase in cases of cancer, autoimmune diseases, inflammatory disorders, and Alzheimer. All these diseases have increased the demand for monoclonal antibodies and higher approvals of mAB will drive the segment growth. For instance, in 2022, the FDA granted an emergency use authorization (EUA) for bebtelovimab, a novel monoclonal antibody for the treatment of COVID-19. Monoclonal antibodies are present in different isoforms, that have varying hydrophobic properties, HIC helps in separating and identifying these isoforms. This data generated after performing HIC can be used to assess the stability and consistency of the mAB products.

Products & Services (Resin, Columns, Buffer, Services)

Hydrophobic interaction chromatography market from the resin segment is expected to garner a significant share of around 40% in the year 2037. Continuous advancements in HIC resin technology are leading the segment’s growth. The development of improved resin has enhanced the performance characteristics. The advanced properties include better resolution, improved selectivity, enhances stability, higher binding capacities, and others.

Our in-depth analysis of the market includes the following segments: